Skip to main
KYTX
KYTX logo

KYTX Market Capitalization Overview

Market Cap: $122.10M as of Jul 2, 2025

$122.10M
Past Month+$11.89M (10.78%)
As of Jul 2, 2025, KYTX has a market capitalization of $122.10M. Over the past 30 days, its market cap has increased by 4.53%, while in the last 12 months, it has decreased by -24.38%.

Market capitalization represents the total value of Kyverna Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

KYTX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of KYTX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

KYTX Market Cap History

DateMarket CapChange
Jul 1, 2025$119.72M+4.53%
Jun 2, 2025$114.54M+19.37%
May 1, 2025$95.95M+12.13%
Apr 1, 2025$85.57M-23.48%
Mar 3, 2025$111.82M-16.45%
Feb 3, 2025$133.84M-20.92%
Jan 2, 2025$169.24M-39.60%

KYTX End of Year Market Cap History

DateMarket CapChange
2025$122.10M-24.38%
2024$161.47M

FAQs About Kyverna Therapeutics Inc (KYTX) Market Cap

As of Jul 2, 2025, the market capitalization of KYTX is $122.10M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Kyverna Therapeutics Inc’s market capitalization has increased by 10.78%, changing from $110.21M to $122.10M as of Jul 2, 2025.

In the last 3 months, Kyverna Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Kyverna Therapeutics Inc’s market capitalization increased from – in January to $161.47M in December, reflecting a — change.

Kyverna Therapeutics Inc (KYTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.